Status:
COMPLETED
New Diabetes Mellitus and Pre-Diabetes With First-time Diagnosed Coronary Artery Disease
Lead Sponsor:
Saud Al Babtain Cardiac Center
Conditions:
PreDiabetes
Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
A prospective analytic study to evaluate the incidence, clinical and laboratory characteristics, extent of coronary artery disease and short-term outcome of newly diagnosed diabetes and pre-diabetes i...
Eligibility Criteria
Inclusion
- First time diagnosed coronary artery disease as confirmed by invasive coronary angiography
- Emergently or electively admitted as coronary artery disease patients.
- Informed consent form
Exclusion
- Prior diagnosis of diabetes or pre-diabetes based on the diagnostic criteria of the American Diabetes Association (ADA, 2020)
- Known coronary artery disease
Key Trial Info
Start Date :
February 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05208424
Start Date
February 27 2020
End Date
September 30 2022
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saud AlBabtain Cardiac Center
Dammam, Saudi Arabia